"In 2023, Massachusetts made up just shy of 15% of the national drug development pipeline and approximately 7% of the global drug development pipeline."
VICE PRESIDENT VALUE CHAIN DEVELOPMENT, RENEWABLE POLYMERS AND CHEMICALS, NESTE
"By replacing fossil raw materials in the polymers and chemicals industry with Neste’s bio-based feedstoc, we can reduce GHG emissions by more than 85% over the life cycle."
EXCLUSIVE SYNTHESIS BU LEADER (AC) & CATALOGUE APIS BU LEADER (RF), DIPHARMA FRANCIS
"The FDA approved 55 new drugs in 2023, of which 34 were small molecules, which is an over 50% increase compared to 2022. This opens new opportunities for Dipharma in the years to come."
"We plan to double our copper production by the end of the decade. There remains significant upside potential in the gold industry, and the copper operations are strategic and additive to that."
"There are many opportunities for the chemical industry to support the development of better communication and efficiency across borders, fostering common regional interest."
LATIN AMERICA GENERAL MANAGER & AMERICAS POLE LEADER SPECIALTY FLUIDS, MOMENTIVE
"The growth of the automotive, aerospace, and electronics markets has ultimately helped our business, allowing us to provide added value in more areas."
"We have made considerable progress, with production levels steadily increasing, reaching 45,000 bpd, and with oil losses and theft being reduced to under 15%."
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.